Notice of Intent to Sole Source: Life Technologies Corp. Custom Taqman Array Cards Tender

Procurement Summary

Country : USA

Summary : Notice of Intent to Sole Source: Life Technologies Corp. Custom Taqman Array Cards

Deadline : 25 Aug 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 87603180

Document Ref. No. : 77603LifeTechnologiesCorp

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Life Technologies Corporation for custom TaqMan Array Cards (product ID 4485460- special gene-x, con4) quantity 700 EA.

The TaqMan Array Cards (TAC) are manufacturered by Life Technologies Corporation (a ThermoFisher Scientific Company). This is the only product that can be used for the spotting of reagents on 384 well cards which will be used for multi-pathogen testing of post-mortem specimens from ongoing mortality surveillance program in nine international sites. These TACs include CDC-developed PCR assays arranged in a customized configuration for detection of approximately 40 pathogen-specific targets. This established technology allows for broader screening for diverse and rare pathogens to identify all causes of death beyond the most common pathogens included in other commercial multipathogen panels and which are unique to the populations under surveillance based on geography (subSaharan Africa and South Asia) and age (stillbirths, neonates, and young children). These custom arrays allow for user-friendly multipathogen screening which would otherwise require substantially higher cost, hands-on time from laboratory staff, and investment in equipment and data management systems. Continued use of this product is required for continuity of specimen testing in this mortality surveillance program in which it is a critical component of collected data, which also includes other laboratory tests and clinical variables .

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within four (4) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for th...
Active Contract Opportunity
Notice ID : 77603LifeTechnologiesCorp
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : CENTERS FOR DISEASE CONTROL AND PREVENTION
Office : CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 21, 2023 03:50 pm EDT
Original Date Offers Due: Aug 25, 2023 03:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Sep 09, 2023
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance: Atlanta, GA 30329 USA

Documents

 Tender Notice

SSJ-for-NOI.pdf